Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-21

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (RISING PHARMA HOLDINGS, INC.)

View source ↗

Summary

The FDA approved oxybutynin chloride as a generic drug under an Original Abbreviated New Drug Application submitted by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)